Vascular neurology questions and answers - part 10 ppt

REFERENCES 287 Camargo EC, Bacheschi LA, Massaro AR. Stroke in Latin America. Neuroimag Clin N Am 2005;15:283–296. Caress JB, Cartwright MS, Donofrio PD, Peacock JE.  e clinical features of 16 case of stroke associated with administration of IVIG. Neurology 2003;60:1822– 1824. Carrera E, Bogousslavsky J.  e thalamus and behavior: Eff ects of anatomically distinct strokes. Neurology 2006;66:1817–1823. Chagan L, Ioselovich A, Asherova L, Cheng JW. Use of alternative pharma- cotherapy in management of cardiovascular disease. Am J Manag Care 2002;8:270–285. Chan KC. Morphological variations of fossa ovalis atrial septal defects (secun- dum): feasibility for transcutaneous closure with the clam-shell device. Br Heart J 1993;69(1):52–55. Chaturvedi S, Levine S (eds.). Transient ischemic attacks. Malden MA: Blackwell Futura, 2004. Chaturvedi S, Lukovits TG, Chen W, Gorelick PB. Ischemic in the territory of a hypoplastic vertebrobasilar system. Neurology 1999;52:980–983. Chavez-Vischer, V., et al. Benign nocturnal alternating hemiplegia of childhood: Six patients and long-term follow-up. Neurology 2001;57:1491. Cheung AT, Pochettino A, McGarvey ML, et al. Strategies to manage paraple- gia risk after endovascular stent repair of descending thoracic aortic aneu- rysms. Ann  orac Surg 2005;80:1288–1289. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–1316. Chobanian A, Bakris GL, Black HR, et al.  e seventh report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560–2572. Cifu DX, Stewart DG. Factors aff ecting functional outcome after stroke: A criti- cal review of rehabilitation interventions. Arch Phys Med Rehabil 1999;80 (5 Suppl 1): S35–S39. Coates DK, Paysse EA, Levy ML. PHACE: A neurocutaneous syndrome with important ophthalmologic implications. Ophthalmology 1999;106:1739– 1741. Futrell 10 Refs.indd 287Futrell 10 Refs.indd 287 11/19/07 10:50:34 AM11/19/07 10:50:34 AM 288 REFERENCES Comu S, Verstraeten T, Rinkoff JS, Busis NA. Neurologic manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke 1996;27:996– 1001. Currier RD. Some aspects on Wallenberg’s lateral medullary syndrome. Neurol- ogy 1961;11:778. Cywinski JB, Parker BM, Lozada LJ, et al. Spontaneous spinal epidural hematoma in a pregnant patient. J Clin Anesth 2004;16:371–375. D’Cruz DP, Khamaschta MA, Hughes GRl. Systemic lupus erythematosus. Lancet 2007;369:587–596. Danik JS, Rifai N, Buring JE, Ridker PM. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovas- cular events among initially healthy women. JAMA 2006;296:1363–1370. Derdeyn CP. Positron emission tomography imaging of cerebral ischemia. Neuro- imag Clin N Am 2005;15:341–350. Di Nisio M, Middledorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028–1040. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007;6:149–161. Diener HC, et al. European Stroke Prevention Study 2. Dipyridamole and acetyl- salicylic acid in the secondary prevention of stroke. J Neuro Sci 1996:143;1– 13. Do TH, Fisch C, Evoy F. Susac syndrome: Report of four cases and review of the literature. Am J Neuroradiol 2004:25:382–388. Drolet BA, Dohil M, Golomb MR, et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006;117:959–964. Droste DW, Kriete JU, Stypmann J, et al. Contrast transcranial Doppler ultra- sound in the detection of right-to-left shunts. Stroke 1999;30:1827–1832. Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilita- tion care: A clinical practice guideline. Stroke. 2005;36:e100. Dussailant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyper- plasia lead to restenosis. J Am Coll Cardiol 1995;26:720–724. Ehtisham A, Stern B. Cerebral venous thrombosis: A review. Neurologist 2006;12:32– 38. Futrell 10 Refs.indd 288Futrell 10 Refs.indd 288 11/19/07 10:50:34 AM11/19/07 10:50:34 AM REFERENCES 289 Elkind MSV, Cole JW. Do common infections cause strokes? Sem Neurol 2006;26:88–99. Engelter ST, Fluri F, Buitrago-Tellez C, et al. Life-threatening orolingual angioede- ma during thrombolysis in acute ischemic stroke. J Neurol 2005;252:1167– 1170. ESPRIT Study Group Medium intensity oral anticoagulants versus aspirin after cerebral ischemia of arterial origin (ESPRIT): A randomized controlled tri- al. Lancet Neurol 2007;6:115–124. Coakley FV, Panicek DM. Iodine allergy: An oyster without a pearl? AJR 1997;169:951–952. Fiehler J. Cerebral microbleeds: Old leaks and new hemorrhages. Int J Stroke 2006:1:122–130. Fields W, Lemak N. A History of Stroke. New York: Oxford University Press, 1989. Fink JN, Selim MH, Kumar S, et al. Is the association of National Institutes of Health Stroke Scale Scores and Acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke? Stroke 2002;33:954 –958. Flossman E. Genetics of ischaemic stroke: Single gene disorders. Int J Stroke 2006;1:131–139. Franchini M. Advances in the diagnosis and management of von Willebrand dis- ease. Hematology 2006;11:219–225. Frangos SG, Chen AH, Sumpio B. Vascular drugs in the new millennium. J Am Coll Surg 2000;191:76. Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 1999;86(11 Suppl):2478–2482. Fukui M, Kono S, Sueishi K, Ikeazaki K. Moyamoya disease. Neuropathology 2000;20:S61–S64. Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neurology 2001;57:1155–1160. Fullerton HJ, Chetkovich DM, Wu YW, et al. Deaths from stroke in US children, 1979–1998. Neurology 2002;59:34–39. Furlan AJ. Unilateral visual loss in bright light. An unusual symptom of carotid occlusive disease. Arch Neurol 1979;36:675. Futrell 10 Refs.indd 289Futrell 10 Refs.indd 289 11/19/07 10:50:34 AM11/19/07 10:50:34 AM 290 REFERENCES Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ ESC Guidelines for the Man- agement of Patients with Atrial Fibrillation. Circulation 2006;113:700–752. Fuster V, ed. Hurst’s  e Heart, 11th ed. New York: McGraw-Hill, 2004. Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992;42:1649–1657. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989;20(5):583–591. Garcia-Monaco R, De Victor D, Mann C, et al. Congestive cardiac manifestations from cerebrocranial arteriovenous shunts. Childs Nerv Syst 1991;7:48–52. Gardiner C, Williams M, Longair I, et al,. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-test- ing. Br J Haematol 2006;132:598–603. Garza CA, Montori VM, McConnell JP, et al. Association between lipoprotein- associated phospholipase A2 and cardiovascular disease: A systemic review. Mayo Clin Proc 2007;82(2):159–165. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hy- perplasia, of cultured rat smooth muscle cell Circulation Res 1988;62:749. Gilman S, Newman SW. Essentials of Clinical Neuroanatomy and Neurophysiol- ogy, 10th ed. Philadelphia: F.A. Davis, 2003. Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. Malden MA: Blackwell Science, 1998. Gladstone DJ, Danells CJ, Armesto A, et al. Physiotherapy coupled with dextro- amphetamine for rehabilitation after hemiparetic stroke : A randomized, double-blind, placebo-controlled trial. Stroke 2006;37:179. Goldenberg-Cohen N, Curry C, Miller NR, et al. Long term visual and neuro- logic prognosis in patients with treated and untreated cavernous sinus an- eurysms. J Neurol Neurosurg Psychiatry 2004;75:863–867. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 2006;296:47–55. Gottesman RF, Sherman PM, Grega MA, et al. Watershed strokes after cardiac surgery: Diagnosis, etiology, and outcome. Stroke 2006;37(9):2306–2311. Futrell 10 Refs.indd 290Futrell 10 Refs.indd 290 11/19/07 10:50:34 AM11/19/07 10:50:34 AM REFERENCES 291 Graham D, Lantos PL. Greenfi eld’s Neuropathology. London: Arnold, 2002. Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology 2004:43;1007–1015. Greenberg DA, Jin K. From angiogenesis to neuropathy. Nature 2005:438;954–959. Greer IA. Anticoagulants in pregnancy. J  romb  rombolysis 2006;21:57. Greer JP, Foerster J, Lukens JN, et al., eds. Wintrobe’s Hematology, 11th ed. Phila- delphia: Lippincott, Williams, Wilkins, 2004. Gregoratos G, et al Cheitlin MD, Conill A, et al. ACC/AHA guidelines for im- plantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998;31:1175–1209. Grotta JC, Chiu D, Lu M, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 1999;30:1528–1533. Gruhn N, Larsen FS, Boesgaard S, et al. Cerebral blood fl ow in patients with chron- ic heart failure before and after heart transplantation. Stroke 2001;32:2350– 2353. Guallar E, Hanley D, Miller ER. An editorial update: Annus horribilis for Vitamin E. Ann Int Med 2005;143:143–145. Guttmacher AE, Callahan JR. Did Robert Louis Stevenson have hereditary hem- orrhagic telangiectasia? Am J Med Genet 2000;91:62–65. Hackett ML, Anderson CS, House AO. Management of depression after a stroke: A systematic review of pharmacological therapies. Stroke 2005;36:1092–1103. Haines DE. Neuroanatomy: An Atlas of Structures, Sections, and Systems, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2004. Halsey JH. Eff ect of emitted power on waveform intensity on transcranial Dop- pler. Stroke 1990;21:1573. Hankey G, Eikelboom J. Aspirin resistance. Lancet 2006;367:606–617. Harnsberger HR, Hudgins PA, MD, Wiggins RH, III, Davidson HC, eds. Diag- nostic Imaging: Head and Neck. Philadelphia: Amirysys-Elsevier Saunders, 2005. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: Overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006;12 Suppl 3:128–136. Futrell 10 Refs.indd 291Futrell 10 Refs.indd 291 11/19/07 10:50:34 AM11/19/07 10:50:34 AM 292 REFERENCES Heart Protection Collaborative Study Group. Eff ects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757– 767. Helgason CM, Bolin KM, Hoff JA, et al. Development of aspirin resistance in per- sons with pervious acute ischemia stroke. Stroke 1994;25:2331–2336. Hennerici M, et al. Vascular Diagnosis with Ultrasound. Stuttgart:  ieme, 1998. Heyer GL, Millar WS, Ghatan S, Garzon MC.  e neurologic aspects of PHACE: Case report and review of the literature. Pediatric Neurol 2006;35:419–424. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, effi - cacy, and safety. Chest 2001;119:64S–94S. Hirsh J, Fuster v, Ansell J, et al. American Heart Association/American College of Cardiology Foundation Guide to Warfarin  erapy. AHA/ACC Scientifi c Statement. J Am Coll Cardiol 2003;41:1633–1652. Hoen B. Epidemiology and antibiotic treatment of infective endocarditis: An up- date. Heart 2006;92:1694–1700. Holmes KW, Kwiterovich PO Jr. Treatment of dyslipidemia in children and ado- lescents. Curr Cardiol Rep 2005;6:445. Howington JU, Kutz SC, Wilding GE, Awasthi D. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99(2): 271–275. Hudson SJ, Brett SJ. Heterotopic ossifi cation—a long-term consequence of pro- longed immobility. Crit Care 2006;10(6):174. Hugl B, Oldenburg WA, Neuhauser B, Hakaim AG. Eff ect of age and gender on restenosis after carotid endarterectomy. Ann Vasc Surg 2006;20:602. Hunt WE, Hess RM. Surgical risk as related to the time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20. Indredavik B, Bakke F, Slordahl SA, et al. Treatment in a combined acute and re- habilitation stroke unit: Which aspects are most important? Stroke 1999;30: 917–923. Intersocietal Accrediation Commission. www.intersocietal.org Futrell 10 Refs.indd 292Futrell 10 Refs.indd 292 11/19/07 10:50:35 AM11/19/07 10:50:35 AM REFERENCES 293 Introcaso CE, Hivnor C, Cowper S, et al. Nephrogenic fi brosing dermopathy/ nephrogenic systemic fi brosis: a case series of nine patients and review of the literature. Int J Dermatol 2007;46:447-452. Jamieson DG, Fu L, Usher DC, et al. Detection of lipoprotein(a) in intraparen- chymal cerebral vessels: Correlation with vascular pathology and clinical history. Exp Mol Pathol 2001;71(2):99–105. Jamieson DG, Parekh A, Ezekowitz MD. Review of antiplatelet therapy in second- ary prevention of cerebrovascular events: A need for direct comparisons between antiplatelet agents. J Cardiovasc Pharmacol  er 2005;10;153. Jennekens FGI, Kater L.  e central nervous system in systemic lupus erythema- tosus. Part 1. Clinical syndromes: A literature investigation. Rheumatology 2002a;41:605–618. Jennekens FGI, Kater L.  e central nervous system in systemic lupus erythema- tosus. Part 2. Pathogenic mechanisms of clinical syndromes: A literature investigation. Rheumatology 2002b;41:619–630. Jensen MB, St Louis EK. Management of acute cerebellar stroke. Arch Neurol 2005;62:537–544. Johansson BB. Brain Plasticity and stroke rehabilitation. Stroke 2000;31:223. Johnson DM, Kramer DC, Cohen E, et al.  rombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen acti- vator. Stroke 2005;36:e53–e55. Johnston DC, Goldstein LB. Clinical carotid endarterectomy decision making: Noninvasive vascular imaging versus angiography. Neurology 2001;56(8): 1009–1015. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Associa- tion Guidelines for the Management of Transient Ischemic Attacks. Ann Neurol 2006;60:301–313. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refi nement of scores to predict very early stroke risk after transient ischemic attack. Lancet 2007;369:283–292. Joo SP, Kim TS, Kim YS, et al. Clinical utility of multislice computed tomograph- ic angiography for detection of cerebral vasospasm in acute subarachnoid hemorrhage. Minim Invasive Neurosurg 2006;49(5):286–290. Jordan L, Hillis A. Hemorrhagic stroke in children. Pediatr Neurology 2007;36;73–80. Futrell 10 Refs.indd 293Futrell 10 Refs.indd 293 11/19/07 10:50:35 AM11/19/07 10:50:35 AM 294 REFERENCES Jordan LC, Hillis AE. Disorders of speech and language: Aphasia, apraxia and dysarthria. Curr Opin Neurol 2006:19:580–585. Jordan LC. Stroke in childhood. Neurologist 2006;12:94–102. Juvela S, Kase C. Advances in intracerebral hemorrhage management. Stroke 2006;37:301–304. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: Pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2006;2(12):661–670. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998;50: 1683–1688. Kasner S. Clinical use and interpretation of stroke scales. Lancet Neuro 2006:5;603–12 Kasner SE, Gorelick PB, eds. Prevention and Treatment of Ischemic Stroke. Phila- delphia: Butterworth Heinemann, 2004. Katz U, Achiron A, Sherer Y, Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev. 2007, 6:257–259. Keane JR. Bilateral ocular paresis. Arch Neurol 2007;64:178. Kelly PJ, Stein J, Shafgat S, et al. Functional recovery following rehabilitation for cerebellar stroke. Stroke 2001;32:530–534. Kent DM. Stroke—An equal opportunity for the initiation of statin therapy. N Engl J Med 2006;355:613–615. Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122(1):311–328. Khuseyinova N, Keonig W. Apolipoprotein A-1 and risk for cardiovascular dis- eases. Curr Athero Rep 2006;8:365–373. Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004;62:1491–1496. Kittner S, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335(11):768–774. Koch C. Spinal dural arteriovenous fi stula. Curr Opin Neurol 2006;19:69–75. Koenig M, Kraus M,  eek C, et al. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001:32:431–437. Futrell 10 Refs.indd 294Futrell 10 Refs.indd 294 11/19/07 10:50:35 AM11/19/07 10:50:35 AM REFERENCES 295 Koenneck H-C. Cerebral microbleeds on MRI: Prevalence, associations, and po- tential clinical implications. Neurology 2006;66:165–171. Kupersmith M. Neurovascular Neuroophthalmology. Berlin: Springer Verlag, 1993. Kurnik K, Kosch A, Sträter R, et al. Recurrent thromboembolism in in- fants and children suff ering from symptomatic neonatal arterial stroke. Stroke;2003:23;2887–2892. Kurth T, Moore S, Gaziano JM, et al. Healthy lifestyle and risk of stroke in wom- en. Arch Intern Med 2006;166:1403–1409. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283–291. Kushner MJ.  e clinical manifestations of pontine hemorrhage. Neurology 1985;35:687. Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol 2005;75(1):57–61. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of child- hood. Neurology 2005;64:660–663. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Co- operative Acute Stroke Study. Stroke 1997; 28(5):957–960. LaSar, CJ, Meier, GH, DeMasi RJ, et al.  e utility of color duplex ultrasonogra- phy in the diagnosis of temporal arteritis. J Vasc Surg 2002;36:1154–1160. Lavi E, Jamieson DG, Granat M. Epidural haemangiomas during pregnancy. J Neu- rol Neurosurg Psychiatry 1986; 49(6):709-712. Leary MC, Finley A, Caplan LR, et al. Cerebrovascular complications of fi bro- muscular dysplasia. Curr Treat Opt Cardiovasc Med 2004;6: 237–248. Lee MS. Movement disorders after lesions of the thalamus or subthalamic region. Mov Disord 1995;9:493. Lee MC, Ausman JI, Geiger JD, et al. Superfi cial temporal to middle cerebral ar- tery anastomosis. Clinical outcome in patients with ischemia of infarction in internal carotid artery distribution. Arch Neurol 1979;36(1):1-4. Leikin JB, Clifton JC, Hanashiro PK, et al. Carbon monoxide poisoning. N Engl J Med 1999;340:1290. Futrell 10 Refs.indd 295Futrell 10 Refs.indd 295 11/19/07 10:50:35 AM11/19/07 10:50:35 AM 296 REFERENCES Leonhardt G, Gaul C, Nietsch HH, et al.  rombolytic therapy in pregnancy. J  romb  rombolysis 2006;21(3):271–276. Levy A. Pituitary disease: Presentation, diagnosis and management. J Neurol Neurosurg Psychiatry 2004:75:iii47. Lindberg J, Prag J, Schǿnheyder HC. Pneumococcal endocarditis is not just a disease of the past. Scand J Infect Dis 1998;5:469–472. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group,  e. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial choles- terol levels. N Engl J Med 1998:339;1349–1357. Lonn E, Yusuf S, Arnold MJ, for HOPE 2 Investigators. Homocysteine lower- ing with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 345:1567–1577. Lopaciuk S, Bykowska K, Kwiecinski H, et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl  romb Hemost 2001;7(4):346–350. Loscalzo J. Homocysteine trials—unclear outcomes for complex reasons. N Engl J Med 2006;354:1629. Love S. Apoptosis and brain ischemia. Prog Neuro-Psychopharmacol Biol Psy- chiatry 2003;27:267–282. MacDonald MG, Mullet MD, Seshia MMK. Avery’s Neonatology, 6th ed. Philadel- phia: Lippincott, Williams, Wilkins, 2005. Manco-Johnson MJ, Grabowski EF, Hellgren M. Recommendations for t-PA thrombolysis in chirldren.  romb Haemost 2002;88:157–158. Manelfe C, Larrue V, von Kummer R, et al, Association of hyperdense MCA sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999;4:769–772. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2001;101:207. Marquez J, Flores D, Candia L, Espinoza LR. Granulomatous vasculitis. Curr Rheum Rep 2003;5:128–135. Masdeu JC, Irimia P, Asenbaum S, et al. EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol 2006;13(12):1271–1283. Futrell 10 Refs.indd 296Futrell 10 Refs.indd 296 11/19/07 10:50:35 AM11/19/07 10:50:35 AM [...]... lupus anticoagulant LDL low-density lipoprotein LMWH low-molecular-weight heparin Lp-PL A2 lipoprotein-associated phospholipase A2 LTP long-term potentiation MAP mean arterial pressure MCA middle cerebral artery MELAS Futrell 11 Abbr.indd 309 fluid-attenuation inversion recovery mitochondrial encephalomyopathy lactic acidosis and stroke-like symptoms 11/19/07 4:29:18 PM 310 A B B R E V I AT I O N S... system Neurology 1989;39;167–173 Morgenstern LB, Viscoli CM, Kernan WN, et al Use of ephedra-containing products and risk for hemorrhagic stroke Neurology 2003;60:132–135 Futrell 10 Refs.indd 297 11/19/07 10: 50:35 AM 298 REFERENCES The Multi-Society Task Force on PVS Medical aspects of the persistent vegetative state: First of two parts N Engl J Med 1994;330:1499–1508 Murugappan A, Coplin WM, Al-Sadat... et al Intracranial aneurysms and subarachnoid hemorrhage in children and adolescents Childs Nervous System 1986;2:185 Futrell 10 Refs.indd 298 11/19/07 10: 50:36 AM REFERENCES 299 Pasternak RC, Smith CS, Bairey-Merz CN, et al ACC/AHA/NHBI clinical advisory on the use and safety of statins J Am Coll Cardiol 2002;40:567–572 Patrono C, Coller B, Fitzgerald GA, et al Platelet-active drugs: The relationships... et al Obstructive sleep apnea as a risk factor for stroke and death N Engl J Med 2005;353:2034–2041 Futrell 10 Refs.indd 305 11/19/07 10: 50:37 AM Futrell 10 Refs.indd 306 11/19/07 10: 50:37 AM ACA ACE angiotensin-converting enzyme ADC apparent diffusion coefficient AED antiepileptic drug AF atrial fibrillation AGS Alagille syndrome AIF apoptosis-inducing factor ANA antinuclear antibody ANCA antineutrophilic... disseminated intravascular coagulopathy dRVVT dilute Russell’s viper venom time DVA developmental venous anomaly DVT deep vein thrombosis DWI diffusion-weighted imaging ECA external carotid artery ECG electrocardiogram EC-IC extracranial-intracranial EDS Ehlers-Danlos syndrome EEG electroencephalogram EMG electromyogram ESR erythrocyte sedimentation rate FDA Food and Drug Administration FDF fibroblast-derived... 2006;8:503–512 Messe SR, Silverman IE, Kizer JR, et al Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2004;62(7) :104 2 105 0 Mettinger KL, Ericson K Fibromuscular dysplasia and the brain Stroke 1982;13: 46–52 Miyakis S, Lockshin MD, Atsumi T, et al International consensus statement... al Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation Circulation 2002 ;105 :1887–1889 Silverman IE, Liu GT, Volpe NJ, Galetta SL The crossed paralyses: The original brain-stem syndromes of Millard-Gubler, Foville, Weber, and RaymondCestan Arch Neurology 1995;52(6);635–638 Smith EE, Greenberg SM Clinical diagnosis of cerebral amyloid... safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone Am J Cardiol 1997;79: 53–57 Toole JF, Malinow MR, Chambless LE, et al Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, Futrell 10 Refs.indd 303 11/19/07 10: 50:36 AM 304 REFERENCES and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized... familial hypercholesterolemia: A randomized controlled trial JAMA 2004;292:331–337 Wijdicks E, Hijdra A, Young GB, et al Practice parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation Neurology 2006;67:203– 210 Futrell 10 Refs.indd 304 11/19/07 10: 50:36 AM REFERENCES 305 Wolf SL, Winstein CJ, Miller JP, et al Effect of constraint-induced movement therapy on upper... stroke: The EXCITE randomized clinical trial JAMA 2006;296:2095– 2104 Wong R, Bequelin GZ, de Lima M, et al Tacrolimus-associated posterior reversible encephalopathy syndrome after allogenic hematopoietic stem cell transplantation Br J Haemat 2003;122:128–134 Woo D, Kissela BM, Khoury JC, et al Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: A case-control study . 2005;353:2034–2041. Futrell 10 Refs.indd 305Futrell 10 Refs.indd 305 11/19/07 10: 50:37 AM11/19/07 10: 50:37 AM Futrell 10 Refs.indd 306Futrell 10 Refs.indd 306 11/19/07 10: 50:37 AM11/19/07 10: 50:37 AM . peptide in hu- mans. J Am Coll Cardiol 1990;16: 1107 . Futrell 10 Refs.indd 300Futrell 10 Refs.indd 300 11/19/07 10: 50:36 AM11/19/07 10: 50:36 AM REFERENCES 301 Rothwell P. Medical and surgical. infarction, Futrell 10 Refs.indd 303Futrell 10 Refs.indd 303 11/19/07 10: 50:36 AM11/19/07 10: 50:36 AM 304 REFERENCES and death:  e Vitamin Intervention for Stroke Prevention (VISP) random- ized controlled